Who owns vTv Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VTVT from SEC Form 13F filings across 45 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 45 institutions disclosed 1.6M shares of vTv Therapeutics Inc. worth $60.5M — about 13% of shares outstanding; the largest disclosed holder is SAMSARA BIOCAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
45
13F holders
$60.5M
value, 2026 filers
13%
of shares outstanding (1.6M sh)
17
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of VTVT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | SAMSARA BIOCAPITAL, LLC | 298,496 | $11.2M | 0.9% | 2.4% | 0.0% |
| 2 | MILLENNIUM MANAGEMENT LLC | 269,874 | $10.2M | 0.0% | 2.2% | +30.8% |
| 3 | FMR LLC | 260,391 | $9.8M | 0.0% | 2.1% | 0.0% |
| 4 | Siren, L.L.C. | 163,000 | $6.1M | 0.1% | 1.3% | 0.0% |
| 5 | BAKER BROS. ADVISORS LP | 148,314 | $5.6M | 0.0% | 1.2% | 0.0% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 94,463 | $3.6M | 0.0% | 0.8% | -13.3% |
| 7 | Trails Edge Capital Partners, LP | 85,192 | $3.2M | 0.5% | 0.7% | -39.0% |
| 8 | Aisling Capital Management LPNEW | 50,000 | $1.9M | 0.4% | 0.4% | new |
| 9 | MARSHALL WACE, LLP | 39,560 | $1.5M | 0.0% | 0.3% | +195.5% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 32,470 | $1.2M | 0.0% | 0.3% | -1.3% |
| 11 | RENAISSANCE TECHNOLOGIES LLCNEW | 17,454 | $657,143 | 0.0% | 0.1% | new |
| 12 | VANGUARD FIDUCIARY TRUST CO | 16,239 | $611,398 | 0.0% | 0.1% | +0.7% |
| 13 | BlackRock, Inc. | 14,731 | $554,622 | 0.0% | 0.1% | +16.9% |
| 14 | JANE STREET GROUP, LLCNEW | 13,703 | $515,918 | 0.0% | 0.1% | new |
| 15 | STATE STREET CORP | 12,266 | $461,815 | 0.0% | 0.1% | +15.0% |
| 16 | TWO SIGMA INVESTMENTS, LPNEW | 11,486 | $432,448 | 0.0% | 0.1% | new |
| 17 | Verdad Advisers, LPNEW | 8,996 | $338,699 | 0.3% | 0.1% | new |
| 18 | Integrated Quantitative Investments LLCNEW | 8,210 | $309,106 | 0.1% | 0.1% | new |
| 19 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 8,023 | $302,066 | 0.0% | 0.1% | new |
| 20 | Quadrature Capital LtdNEW | 6,305 | $237,383 | 0.0% | 0.1% | new |
| 21 | Trexquant Investment LPNEW | 6,240 | $234,936 | 0.0% | 0.1% | new |
| 22 | NORTHERN TRUST CORP | 6,123 | $230,531 | 0.0% | 0% | -66.1% |
| 23 | Pathstone Holdings, LLC | 6,073 | $228,664 | 0.0% | 0% | 0.0% |
| 24 | Point72 Asset Management, L.P.NEW | 5,947 | $223,905 | 0.0% | 0% | new |
| 25 | HRT FINANCIAL LPNEW | 5,923 | $223,000 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.